Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

17 Jul 2013 07:00

RNS Number : 4730J
Imperial Innovations Group plc
17 July 2013
 



17 July 2013

 

Imperial Innovations Group plc

 

Board change

 

Imperial Innovations Group plc (AIM: IVO, "Innovations" or "the Group"), a leading technology commercialisation and investment group, announces that Susan Searle has stepped down as Chief Executive Officer. Russ Cummings, Chief Investment Officer and a director since the Group's flotation in 2006, has become Chief Executive Officer with immediate effect.

 

Russ Cummings previously worked at Scottish Equity Partners where as director in the Information Technology Group he was responsible for investment in high growth technology companies. Previously, Russ worked at 3i Group for 16 years including being a director in their UK Technology Group and at Rolls-Royce Motors as a development engineer. Russ has a BSc in Mechanical Engineering from Imperial College London.

 

Martin Knight, Chairman of the Group, said:

 

"On behalf of the Board and the Group as whole, I would like to thank Susan for her considerable contribution over the last nearly 20 years, 11 of which have been as Chief Executive Officer. She led our Admission to AIM in 2006 and two subsequent equity fund raisings.

 

"During her tenure, she transformed the Group from an operational division of Imperial College London, as its technology transfer office, to a major independent venture capital and technology licensing business.

 

"Thanks to her efforts, Innovations now has a stable platform from which it can deliver its long-term ventures and licensing business objectives. We all wish her well for the future.

 

"Russ has an excellent track record in early stage investing and high growth companies spanning both the healthcare and technology sectors. He was recruited in 2006 as CIO to build the investment team. He has played a significant role on the boards of two of our flagship investments, Nexeon and Circassia.

 

"Russ has been a key part of the management team and is ideally suited to lead Innovations in the next phase of its development."

 

Susan Searle said:

 

"I feel privileged for over 11 years to have led the management team at Innovations in building such a great company that it is today. But I have decided that now is the right time for me to step down. The timing of this decision is both good for me and for the business and enables my successor to make a very smooth transition to his role.

 

"The business is currently in a strong position and has recently concluded an additional £30m of funding from the European Investment Bank, enabling the Group to grow its investments still further. Innovations has some very exciting companies in its portfolio which we have worked hard to support and are based on world class science, with high quality management and are backed by strong investment syndicates.

 

"The Innovations story is set to continue and thrive in the long term and I wish it and the team every success.

 

"I now plan to go plural and to join a number of both larger and smaller public and private companies across a range of sectors, including biotech, engineering and technology, and investment in the UK and internationally."

 

Enquiries:

 

Imperial Innovations Group Plc

020 7594 6506

Martin Knight, Chairman

College Hill

020 7457 2020

Adrian Duffield/Tim Watson/Rozi Morris

J.P. Morgan Cazenove

020 7742 4000

Michael Wentworth Stanley/Alec Pratt

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUCCMUPWGQQ
Date   Source Headline
12th Dec 20123:02 pmRNSResult of AGM
16th Nov 20127:00 amRNSVeryan CE Mark approval for BioMimics 3D Stent
5th Nov 20127:00 amRNSPortfolio companies receive government funding
19th Oct 201210:00 amRNSGrant of share options
5th Oct 20127:00 amRNSFull year results
4th Oct 20127:00 amRNSCircassia initiates phase III trial
26th Sep 20127:00 amRNSPsiOxus commences clinical trial
20th Sep 201212:39 pmRNSNotice of Results
13th Sep 20123:25 pmRNSCircassia appoints Dr Brett Haumann as CMO
12th Sep 201211:35 amRNSAward Win
6th Sep 20127:00 amRNSInvestment in Cambridge technology company
1st Aug 20123:58 pmRNSDirector Dealings
23rd Jul 20127:00 amRNSInvestment in portfolio company
11th Jul 20122:50 pmRNSVeryan Medical appoints new COO and NEDs
9th Jul 20127:00 amRNS£22m funding round for PsiOxus Therapeutics
5th Jul 20125:20 pmRNSGrant of share options
27th Jun 20128:12 amRNSAbingdon Health acquires controlling stake
18th Jun 20127:00 amRNSInvestment in Oxford healthcare company
12th Jun 20127:00 amRNSInvestment in Cambridge technology company
31st May 20129:36 amRNSDirector/PDMR Shareholding
29th May 201210:05 amRNSPolytherics expands relationship with Pro Bono Bio
24th May 20127:00 amRNSDirector Dealings
1st May 20123:04 pmRNSDirector Dealings
23rd Apr 20127:00 amRNSHalf year results
26th Mar 20123:51 pmRNSNotice of Results
26th Mar 20127:00 amRNSInvestment in portfolio company
21st Mar 20127:00 amRNSDirectorate Change
8th Mar 20127:00 amRNSCircassia Phase II Clinical Trial Success
13th Feb 20127:00 amRNSInvestment in portfolio company
14th Dec 20115:27 pmRNSResult of AGM
6th Dec 20117:00 amRNSInvestment in new start-up
5th Oct 20117:00 amRNSFinal Results
27th Sep 20118:56 amRNSNotice of Results
7th Sep 20117:00 amRNSFurther investment in portfolio company
25th Aug 20117:00 amRNSInvestment in Cambridge company
22nd Aug 20117:00 amRNSInvestment in new company
3rd Aug 20117:00 amRNSInvestment in portfolio company
20th Jul 20117:00 amRNSInvestment in Stanmore
22nd Jun 20119:35 amRNSPortfolio company joint venture
19th Apr 20117:00 amRNSCircassia raises £60m
19th Apr 20117:00 amRNSHalf Yearly Report
30th Mar 201112:41 pmRNSNotice of Results
7th Feb 20116:00 pmRNSNotification of major interest in shares
3rd Feb 20118:16 amRNSDirectors' Dealings
27th Jan 20112:56 pmRNSNotification of major interest in shares
27th Jan 20112:51 pmRNSNotification of major interest in shares
26th Jan 20116:01 pmRNSNotification of major interest in shares
25th Jan 20116:03 pmRNSDirectors' Dealings
25th Jan 20115:40 pmRNSResults of Rump placing
24th Jan 20114:11 pmRNSVoting rights & share capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.